www.econotimes.com Open in urlscan Pro
45.55.62.251  Public Scan

Form analysis
2 forms found in the DOM

Name: formSearch — GET /search

<form name="formSearch" action="/search" method="get">
  <input type="text" name="v" id="globSearch" placeholder="Enter Keyword">
  <button type="submit" class="searchBtn" name="search">Search </button>
</form>

Name: freeAccessForm — POST

<form method="post" name="freeAccessForm" id="freeAccessForm">
  <div class="emailWrap">
    <input type="text" name="email" class="mailDirect" placeholder="Enter your E-mail">
    <input type="submit" id="btnMailDirect" value="Subscribe">
  </div>
</form>

Text Content

Menu

Search

  |   Business
Become a contributor
Bookmark Econotimes

Menu

  |   Business

Search

日 코로나 제한 풀자 관광업 '활짝'...소매 판매 9개월 연속 증가세

Jeju draws record 13.59 million domestic tourists for 2022

US govt to probe Southwest Airlines over 'unacceptable' flight cancellations,
delays

AT&T, BlackRock signs joint venture agreement to offer fastest fiber optic
services

올해 제주도 방문객 1300만명 넘었다...역대 최다 기록

US FDA to weigh safety of cannabis compound CBD in food, supplements

Hyundai Motor Group EVs receive highest rating in collision tests

EMart24 convenience store chain lands in Singapore, opens first outlet to sell
K-food

Korean Air, Asiana merger secures China’s approval, now awaiting EU decision

New York to ban pet stores from selling animals by 2024

Domino’s Pizza opens outlets in Rishikesh, Bhubaneswar

Finnair to increase flights to Japan, Hong Kong, India in summer

Hanwha, Doosan announces team up for wine business, aim to complete with Lotte
and Shinsegae

Hyundai Motor, Kia to enter market for used car-selling business

BMW expands EV chargers in Korea by opening the largest charging station

Grizzlies star Ja Morant unveils signature Nike shoe in Christmas day loss vs
Warriors

Apple supplier TSMC to begin mass production of 3nm chips this week, report says

日 코로나 제한 풀자 관광업 '활짝'...소매 판매 9개월 연속 증가세

Jeju draws record 13.59 million domestic tourists for 2022

US govt to probe Southwest Airlines over 'unacceptable' flight cancellations,
delays

AT&T, BlackRock signs joint venture agreement to offer fastest fiber optic
services

올해 제주도 방문객 1300만명 넘었다...역대 최다 기록

US FDA to weigh safety of cannabis compound CBD in food, supplements

Hyundai Motor Group EVs receive highest rating in collision tests

EMart24 convenience store chain lands in Singapore, opens first outlet to sell
K-food

Korean Air, Asiana merger secures China’s approval, now awaiting EU decision

New York to ban pet stores from selling animals by 2024

prev
next



Search

 * News
 * Economy
 * Central Banks
 * Investing
 * Research
 * Roundups
 * Digital Currency
 * Insights
 * Technical Analysis
 * Technology
 * Business
 * Law
 * Health
 * Nature
 * Fintech
 * Science
 * Topic
 * Opinions

 * About us
 * Advertise With Us
 * Contribute
 * Contact us
 * Institutional Service

 * Privacy Policy
 * Terms of Service
 * Disclaimer

 * ©Elmin Media 2022. All Rights Reserved.

 * 

 * 

 * 0

 * 0

 * 

 * 

 * 
 * 
 * 

Medicago ditches Philip Morris as WHO disproves plant-based COVID-19 vaccine

Photo by: Medicago Website

Wednesday, December 28, 2022 6:50 AM UTC


RELATED STORIES

 * Philip Morris buying Swedish Match tobacco firm

Medicago Inc. has been developing a plant-based vaccine for COVID-19, and for
this project, it has teamed up with some companies, including Philip Morris. The
World Health Organization recently rejected its vaccine and with this, the
Canadian biotechnology company decided to sever ties with the cigarette maker.

According to Bloomberg, Medicago submitted a request for the emergency-use
listing of its plant-based COVID-19 vaccine but WHO did not grant its approval
earlier this year. It was reported that the reason for the rejection was the
biotech firm’s links with the tobacco industry.

Medicago made Covifenz which was dubbed as the first plant-based COVID vaccine
in the world. It was jointly developed by Medicago and GlaxoSmithKline but the
Canadian government contributed to the funding of its development by providing
$173 million. The Canadian biotech firm is also 25% owned by Philip Morris.

However, despite the successful tests and approval from Health Canada, WHO gave
the opposite decision; thus, it cannot be shipped anywhere else. This outcome
pushed Medicago to drop Philip Morris from the COVID-19 vaccine collaboration.

The company’s move to eject the cigarette maker from the project was highly
praised by civil society, and proceeded to plead with all governments to avoid
working with tobacco companies in the future.

"Tobacco corporations, vaccines and governments do not mix well and we applaud
the expulsion of Philip Morris from the Medicago collaboration," executive
director of the non-profit organization Action on Smoking & Health (ASH) Canada,
Les Hagen, said in a press release. "Tobacco industry products are responsible
for over eight million deaths annually worldwide and tobacco corporations are
desperately trying to whitewash their terrible public image by investing in the
health sector.”

Hagen added that they are pleased that Canadian governments have decided to not
get involved with a company in the tobacco business any longer. He also
described the initial partnership as an “unethical and embarrassing
collaboration with a tobacco giant."

Corporate Accountability's tobacco campaign director, Daniel Dorado, added, "Now
that Philip Morris has been ejected from this collaboration, we urge Canadian
governments to fully comply with the treaty by closing the barn door on any
future tobacco industry partnerships."







EDITOR'S PICKS

Exercise really can help you sleep better at night – here's why that may be

What is the 'carnivore diet' and is it a bad idea?

Can gaming 'addiction' lead to depression or aggression in young people? Here’s
what the evidence says

Is the metaverse really the future of work?

Can the EU's Digital Markets Act rein in big tech?

Can big data really predict what makes a song popular?

DNA is often used in solving crimes. But how does DNA profiling actually work?

USDA approves genetically-modified purple tomato

These stunning satellite images look like abstract art – and they reveal much
about our planet

 * Market Data

Market Data by TradingView
Financial Markets by TradingView

Most Popular
1

Hyundai Motor, Kia to enter market for used car-selling business

2

Kosovo minister accuses Serbia of trying to destabilize country

3

Toyota's global production hits record high in November as supply crunch eases

4

Hyundai Mobis, Sinclair partner to provide state-of-the-art vehicle broadcast
system

5

BMW expands EV chargers in Korea by opening the largest charging station

6

AT&T, BlackRock signs joint venture agreement to offer fastest fiber optic
services

7

US FDA to weigh safety of cannabis compound CBD in food, supplements

8

Japan to deploy missile defense system in Yonaguni island

9

Kuo: iPad mini 7 is in the works with a new chip and could be released in late
2023

10

FxWirePro- Cryptos to look out for - RLC



> EconoTimes



Back to Top ▲

©Elmin Media 2022. All Rights Reserved. By using this site, you agree to the
Terms of Service, Privacy Policy, and Cookie Policy.

 * 
 * 
 * 
 * 
 * 

 * About us
 * Advertise with us
 * Contribute
 * Contact Us

Disclaimer: EconoTimes provides references and links to selected blogs and other
sources of economic and market information as an educational service to its
clients and prospects and does not endorse the opinions or recommendations of
the blogs or other sources of information. Clients and prospects are advised to
carefully consider the opinions and analysis offered in the blogs or other
information sources in the context of the client or prospect's individual
analysis and decision making. None of the blogs or other sources of information
is to be considered as constituting a track record. Past performance is no
guarantee of future results and EconoTimes specifically advises clients and
prospects to carefully review all claims and representations made by advisors,
bloggers, money managers and system vendors before investing any funds or
opening an account with any Brokerage. Any news, opinions, research, data, or
other information contained within this website is provided as general market
commentary and does not constitute investment or trading advice. EconoTimes
expressly disclaims any liability for any lost principal or profits without
limitation which may arise directly or indirectly from the use of or reliance on
such information. As with all such advisory services, past results are never a
guarantee of future results.

EconoTimes. Elmin Media LLC. All Rights Reserved. | 17 Seonyu-ro 49-gil,
Yeongdeungpo-gu, Seoul, South Korea

Newspaper Registration No. Seoul A04906 | Registration Date. 2018.01.02

Publisher/Editor. Sungmin Kwon | Juvenile Protection Manager. Seokjin Yoon

Tel. +82.2.6332.2245


WELCOME TO ECONOTIMES

Sign up for daily updates for the most important
stories unfolding in the global economy.